Confirmation required

This area of the website is exclusively reserved for Health Professionals. By clicking on "Confirm", I confirm that I am a Health Professional.

Dynamics

What is common to all the fillers you have been using so far? Do they allow
you to enhance and rejuvenate your patients’ faces? Yes, most of them do.
But were they designed bearing in mind that a face is everything but static?

With TEOSYAL®RHA, hyaluronic acid is going through an innovative manufacturing process3, in order to create the first resilient hyaluronic acid4 dedicated to facial dynamism.

1. TEOXANE Laboratories crosslinking method is a patented process. 2. TEOSYAL®RHA keeps its mechanical properties on a large range of strain or stress constraints (dynamic G’) Report Rheological characterizations of hyaluronic acid gels. Rheonova (University of Grenoble, France). Data on file - Patent pending. TEOSYAL®RHA 1 to 4 are medical devices class III (CE 0086), please refer to instructions of use. 3. TEOXANE Laboratories crosslinking method is a patented process. 4. TEOSYAL®RHA keeps its mechanical properties on a large range of strain or stress constraints (dynamic G’) Report Rheological characterizations of hyaluronic acid gels. Rheonova (University of Grenoble, France). Data on file - Patent pending.

 

WELCOME TO THE ERA OF DYNAMIC AESTHETICS 

 

HA concentration
(mg/mL)
15  

                                                                                                                                                                     

Lidocaine
concentration
0.3%  

                                                            

Crosslinker rate1 1.9%  

                                                            

                                                            

Packaging 2 x 1mL  

                                                            

Needle 30G 1/2"  

 

                                                   Characteristics of TEOSYAL®RHA gels2
 

 


 

HA concentration
(mg/mL)
23  

                                                                                                           

Lidocaine
concentration
0.3%  

                                                            

Crosslinker rate1 3.1%  

                                                            

                                                            

Packaging 2 x 1mL  

                                                            

Needle 30G 1/2"  

 

                                                   Characteristics of TEOSYAL®RHA gels3
 

 


 

HA concentration
(mg/mL)
23  

                                                                                                           

Lidocaine
concentration
0.3%  

                                                            

Crosslinker rate1 3.6%  

                                                            

                                                            

Packaging 2 x 1mL  

                                                            

Needle 27G 1/2’’  

                                             

                               Characteristics of TEOSYAL®RHA gels4
 

 


 

HA concentration
(mg/mL)
23  

                                                                                                           

Lidocaine
concentration
0.3%  

                                                            

Crosslinker rate1 4.0%  

                                                            

                                                            

Packaging 2 x 1mL  

                                                            

Needle 27G 1/2’’  

 

                                                   Characteristics of TEOSYAL®RHA gels5
 

1. TEOXANE. Data on file, measurement by an independent laboratory of the HA Degree of Modification by 1H NMR. 2. Teosyal®RHA 1. Please refer to instructions of use. 3. Teosyal®RHA 2. Please refer to instructions of use. 4. Teosyal®RHA 3. Please refer to instructions of use. 5. Teosyal®RHA 4. Please refer to instructions of use.